Public health priorities - The cost-effectiveness of HIV control: Getting the priorities right

by Gesine Meyer-Rath
Published 2007-05-01

HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.

by Gesine Meyer-Rath, Mead Over
Published 2012-01-01

When donor funding leaves: an interrupted time-series analysis of the impact of integrating direct HIV care and treatment into public health services in a region of Johannesburg

by Naomi Lince-Deroche, Rahma Leuner, Gesine Meyer-Rath, Yogan Pillay, Lawrence Long
Published 2019-10-01

Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case.

by Gesine Meyer-Rath, Craig van Rensburg, Bruce Larson, Lise Jamieson, Sydney Rosen
Published 2017-01-01

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?

by Calvin Chiu, Leigh F. Johnson, Lise Jamieson, Bruce A. Larson, Gesine Meyer-Rath
Published 2017-01-01

The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case.

by Gesine Meyer-Rath, Craig van Rensburg, Calvin Chiu, Rahma Leuner, Lise Jamieson, Steve Cohen
Published 2019-01-01

Attrition through multiple stages of pre-treatment and ART HIV care in South Africa.

by Matthew P Fox, Kate Shearer, Mhairi Maskew, Gesine Meyer-Rath, Kate Clouse, Ian Sanne
Published 2014-01-01

Modelling costs of community-based HIV self-testing programmes in Southern Africa at scale: an econometric cost function analysis across five countries

by Gabriela B Gomez, Gesine Meyer-Rath, Collin Mangenah, Linda Alinafe Sande, Marc d'Elbée, Lawrence Mwenge, Graham F Medley
Published 2021-07-01

The impact and cost of scaling up GeneXpert MTB/RIF in South Africa.

by Gesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, William MacLeod, Ian Sanne, Wendy Stevens, Sagie Pillay, Yogan Pillay, Sydney Rosen
Published 2012-01-01

Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study.

by Jacob Bor, Shahira Ahmed, Matthew P Fox, Sydney Rosen, Gesine Meyer-Rath, Ingrid T Katz, Frank Tanser, Deenan Pillay, Till Bärnighausen
Published 2017-01-01

The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis.

by Gesine Meyer-Rath, Jan Pienaar, Brian Brink, Andrew van Zyl, Debbie Muirhead, Alison Grant, Gavin Churchyard, Charlotte Watts, Peter Vickerman
Published 2015-09-01

Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia

by Hari S. Iyer, Callie A. Scott, Deophine Lembela Bwalya, Gesine Meyer-Rath, Crispin Moyo, Carolyn Bolton Moore, Bruce A. Larson, Sydney Rosen
Published 2014-01-01

Prospects for HIV control in South Africa: a model-based analysis

by Leigh F. Johnson, Calvin Chiu, Landon Myer, Mary-Ann Davies, Rob E. Dorrington, Linda-Gail Bekker, Andrew Boulle, Gesine Meyer-Rath
Published 2016-06-01

The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis

by Gesine Meyer-Rath, Mohammed Majam, Leigh F Johnson, Katleho Matsimela, Linda Alinafe Sande, Thato Chidarikire, Marc d'Elbée, Lise Jamieson, Brooke Nichols
Published 2021-07-01

Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study.

by Katharina Kranzer, Stephen D Lawn, Gesine Meyer-Rath, Anna Vassall, Eudoxia Raditlhalo, Darshini Govindasamy, Nienke van Schaik, Robin Wood, Linda-Gail Bekker
Published 2012-01-01

Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis.

by Callie A Scott, Hari Iyer, Deophine Lembela Bwalya, Kelly McCoy, Gesine Meyer-Rath, Crispin Moyo, Carolyn Bolton-Moore, Bruce Larson, Sydney Rosen
Published 2013-01-01

Changing the South African national antiretroviral therapy guidelines: The role of cost modelling.

by Gesine Meyer-Rath, Leigh F Johnson, Yogan Pillay, Mark Blecher, Alana T Brennan, Lawrence Long, Harry Moultrie, Ian Sanne, Matthew P Fox, Sydney Rosen
Published 2017-01-01

The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa

by Gesine Meyer-Rath, Mohammed Majam, Vincent Zishiri, Jane Phiri, Katleho Matsimela, Linda Alinafe Sande, Cyprian Mostert, Celeste Madondo, Stephen Khama, Thato Chidarikire, Marc d'Elbée
Published 2021-07-01

Costs of integrating HIV self-testing in public health facilities in Malawi, South Africa, Zambia and Zimbabwe

by Hendramoorthy Maheswaran, Gesine Meyer-Rath, Helen Ayles, Mohammed Majam, Euphemia Lindelwe Sibanda, Collin Mangenah, Katleho Matsimela, Linda Alinafe Sande, Cyprian Mostert, Marc d'Elbée, Lawrence Mwenge, Augustine Talumba Choko, Inonge Matamwandi
Published 2021-07-01

Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints.

by Evelinn Mikkelsen, Jan A C Hontelez, Maarten P M Jansen, Till Bärnighausen, Katharina Hauck, Kjell A Johansson, Gesine Meyer-Rath, Mead Over, Sake J de Vlas, Gert J van der Wilt, Noor Tromp, Leon Bijlmakers, Rob M P M Baltussen
Published 2017-02-01